Middle East & Africa Subcutaneous Drug Delivery Devices Market Size & Outlook
Middle East & Africa subcutaneous drug delivery devices market, 2018-2030 (US$M)
Related Markets
MEA subcutaneous drug delivery devices market highlights
- The MEA subcutaneous drug delivery devices market generated a revenue of USD 1,312.6 million in 2023.
- The market is expected to grow at a CAGR of 8.7% from 2024 to 2030.
- In terms of segment, pen injectors was the largest revenue generating product in 2023.
- Wearable injectors is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 1,312.6 million |
| Market revenue in 2030 | USD 2,357.6 million |
| Growth rate | 8.7% (CAGR from 2023 to 2030) |
| Largest segment | Pen injectors |
| Fastest growing segment | Wearable injectors |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Prefilled syringes, Pen injectors, Auto-injectors, Wearable injectors, Needle-free injectors |
| Key market players worldwide | Gerresheimer AG ADR, Medtronic PLC, Ypsomed Holding AG, Novo Nordisk A/S ADR, Insulet Corp, Becton Dickinson & Co, West Pharmaceutical Services Inc, PHARMAJET, Unilife Corporation |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.2% of the global subcutaneous drug delivery devices market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 13,711.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Subcutaneous Drug Delivery Devices Market Scope
Subcutaneous Drug Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa subcutaneous drug delivery devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to subcutaneous drug delivery devices market will help companies and investors design strategic landscapes.
Pen injectors was the largest segment with a revenue share of 38.67% in 2023. Horizon Databook has segmented the Middle East & Africa subcutaneous drug delivery devices market based on prefilled syringes, pen injectors, auto-injectors, wearable injectors, needle-free injectors covering the revenue growth of each sub-segment from 2018 to 2030.
Middle East & Africa (MEA) is growing at a moderate rate owing to several factors, such as high spending capacity & living standards, the presence of well-established medical infrastructure, and increasing number of cancer cases.
The high cancer prevalence, coupled with an increasing preference for early disease diagnosis, is expected to drive market growth. In addition, growing government initiatives to increase reimbursement coverage are expected to boost market penetration during the forecast period.
Reasons to subscribe to Middle East & Africa subcutaneous drug delivery devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa subcutaneous drug delivery devices market databook
-
Our clientele includes a mix of subcutaneous drug delivery devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa subcutaneous drug delivery devices market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa subcutaneous drug delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA subcutaneous drug delivery devices market size, by country, 2018-2030 (US$M)
Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
